Table of Contents Author Guidelines Submit a Manuscript
Retracted

Evidence-Based Complementary and Alternative Medicine has retracted this article. The article was found to contain images with the following concerns: There are irregularities in the background in Figures and ; the tubulin controls in Figures and are the same; Figure , Cyclin B (72 hrs) is the same as Figure , TGF beta1 (24 hrs); Figure , the lanes in the TGF-alpha rows at 6 hours and 72 hours do not align. The authors provided corrected figures, which are available as Supplementary Materials, but could not provide the underlying blots.

View the full Retraction here.

References

  1. J.-P. Wu, C.-C. Tsai, Y.-L. Yeh et al., “Silymarin accelerates liver regeneration after partial hepatectomy,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 603529, 14 pages, 2015.
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 603529, 14 pages
http://dx.doi.org/10.1155/2015/603529
Research Article

Silymarin Accelerates Liver Regeneration after Partial Hepatectomy

1Graduate Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan
2School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 84001, Taiwan
3Chinese Medicine Department, E-Da Hospital, Kaohsiung 82445, Taiwan
4Department of Pathology, Changhua Christian Hospital, Changhua 50006, Taiwan
5Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 35664, Taiwan
6Orthopaedic Department, Armed Forces General Hospital, Taichung 32551, Taiwan
7Department of Nursing, Meiho University, Pingtung 91202, Taiwan
8Department of Biotechnology, Bharathiar University, Coimbatore 641 046, India
9Cardiology Department of Taichung Armed Forces General Hospital, Taichung 32551, Taiwan
10Graduate Institute of Chinese Medical Science, China Medical University, Taichung 40402, Taiwan
11Department of Health and Nutrition Biotechnology, Asia University, Taichung 41354, Taiwan

Received 11 September 2014; Revised 15 January 2015; Accepted 22 January 2015

Academic Editor: Ravirajsinh N. Jadeja

Copyright © 2015 Jia-Ping Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Wellington and B. Jarvis, “Silymarin: a review of its clinical properties in the management of hepatic disorders,” BioDrugs, vol. 15, no. 7, pp. 465–489, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Loguercio and D. Festi, “Silybin and the liver: from basic research to clinical practice,” World Journal of Gastroenterology, vol. 17, no. 18, pp. 2288–2301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Cengiz, H. M. Kutlu, D. D. Burukoglu, and A. Ayhanci, “A comparative study on the therapeutic effects of silymarin and silymarin-loaded solid lipid nanoparticles on d-GaIN/TNF-α-induced liver damage in balb/c mice,” Food and Chemical Toxicology, vol. 77, pp. 93–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. P. V. Kiruthiga, R. B. Shafreen, S. K. Pandian, and K. P. Devi, “Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes,” Basic & Clinical Pharmacology & Toxicology, vol. 100, no. 6, pp. 414–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Saller, R. Meier, and R. Brignoli, “The use of silymarin in the treatment of liver diseases,” Drugs, vol. 61, no. 14, pp. 2035–2063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. C. Pradhan and C. Girish, “Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine,” Indian Journal of Medical Research, vol. 124, no. 5, pp. 491–504, 2006. View at Google Scholar · View at Scopus
  7. G. K. Michalopoulos and M. C. DeFrances, “Liver regeneration,” Science, vol. 276, no. 5309, pp. 60–66, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Fan, Y. Ma, Y. Liu, D. Zheng, and G. Huang, “Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells,” European Journal of Pharmacology, vol. 743, pp. 79–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. N. M. El-Lakkany, O. A. Hammam, W. H. El-Maadawy, A. A. Badawy, A. A. Ain-Shoka, and F. A. Ebeid, “Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis,” Parasites and Vectors, vol. 5, no. 1, article 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Yang, L. Zhuang, Y. Lu, Q. Xu, and X. Chen, “Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials,” BioMed Research International, vol. 2014, Article ID 941085, 9 pages, 2014. View at Publisher · View at Google Scholar
  11. N. Kumar, A. Rai, N. D. Reddy et al., “Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells,” Pharmacological Reports, vol. 66, no. 5, pp. 788–798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Fausto, A. D. Laird, and E. M. Webber, “Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration,” The FASEB Journal, vol. 9, no. 15, pp. 1527–1536, 1995. View at Google Scholar
  13. T. Ishikawa, V. M. Factor, J. U. Marquardt et al., “Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice,” Hepatology, vol. 55, no. 4, pp. 1215–1226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Gui, M. Yeganeh, S. Ramanathan et al., “SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes,” Journal of Hepatology, vol. 55, no. 6, pp. 1300–1308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Okumura, T. Seki, and T. Ariga, “Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 6, pp. 1542–1549, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Shanmukhappa, G. E. Sabla, J. L. Degen, and J. A. Bezerra, “Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor,” BMC Gastroenterology, vol. 6, article 40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Bueno, S. Salgado, C. Beas-Zárate, and J. Armendariz-Borunda, “Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF,” Journal of Gene Medicine, vol. 8, no. 11, pp. 1291–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-I. Okano, G. Shiota, K. Matsumoto et al., “Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway,” Biochemical and Biophysical Research Communications, vol. 309, no. 2, pp. 298–304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Khoshnoodi, N. Fakhraei, and A. R. Dehpour, “Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice,” Pharmaceutical Biology, vol. 53, no. 5, pp. 739–745, 2015. View at Publisher · View at Google Scholar
  20. C.-Y. Chiu, K.-K. Kuo, T.-L. Kuo, K.-T. Lee, and K.-H. Cheng, “The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration,” Molecular Cancer Research, vol. 10, no. 3, pp. 415–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. F. Barreto, S. N. Wallace, D. J. Carrier, and E. C. Clausen, “Extraction of nutraceuticals from milk thistle: I. Hot water extraction,” Applied Biochemistry and Biotechnology—Part A: Enzyme Engineering and Biotechnology, vol. 108, no. 1-3, pp. 881–890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Duan, S. N. Wallace, A. Engelberth et al., “Extraction of co-products from biomass: example of thermal degradation of silymarin compounds in subcritical water,” Applied Biochemistry and Biotechnology, vol. 158, no. 2, pp. 362–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. N. Tzirogiannis, K. T. Kourentzi, S. Zyga et al., “Effect of 5-HT 7 receptor blockade on liver regeneration after 60–70% partial hepatectomy,” BMC Gastroenterology, vol. 14, no. 1, article 201, 2014. View at Google Scholar
  24. A. N. Kandilis, J. Koskinas, I. Vlachos et al., “Liver regeneration: immunohistochemichal study of intrinsic hepatic innervation after partial hepatectomy in rats,” BMC Gastroenterology, vol. 14, no. 1, article 202, 2014. View at Publisher · View at Google Scholar
  25. H. J. Eo, G. H. Park, H. M. Song et al., “Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells,” International Immunopharmacology, vol. 24, no. 1, pp. 1–6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. L. H. Li, L. J. Wu, S. I. Tashiro, S. Onodera, F. Uchiumi, and T. Ikejima, “The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis,” International Immunopharmacology, vol. 6, no. 2, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Benko, S. Frede, Y. Gu et al., “Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat,” Journal of Investigative Surgery, vol. 23, no. 1, pp. 12–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. O. El Mesallamy, N. S. Metwally, M. S. Soliman, K. A. Ahmed, and M. M. Abdel Moaty, “The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats,” Cancer Cell International, vol. 11, no. 1, article 38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Reisinger, S. Schaumberger, V. Nagl, S. Hessenberger, and G. Schatzmayr, “Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro,” Toxins, vol. 6, no. 10, pp. 2962–2974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Vaid, R. Prasad, Q. Sun, and S. K. Katiyar, “Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells,” PLoS ONE, vol. 6, no. 7, Article ID e23000, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-J. Kwon, Y.-S. Won, Y.-D. Yoon et al., “Vitamin D3 up-regulated protein 1 deficiency accelerates liver regeneration after partial hepatectomy in mice,” Journal of Hepatology, vol. 54, no. 6, pp. 1168–1176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Fehér and G. Lengyel, “Silymarin in the prevention and treatment of liver diseases and primary liver cancer,” Current Pharmaceutical Biotechnology, vol. 13, no. 1, pp. 210–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. F. J. Burczynski, G. Wang, D. Nguyen, Y. Chen, H. J. Smith, and Y. Gong, “Silymarin and hepatoprotection,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 37, no. 1, pp. 6–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Ramasamy and R. Agarwal, “Multitargeted therapy of cancer by silymarin,” Cancer Letters, vol. 269, no. 2, pp. 352–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-C. Tsai, J.-P. Wu, Y.-M. Lin et al., “The effect of Elephantopus scaber L. on liver regeneration after partial hepatectomy,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 369180, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. T. Atawia, H. H. Mosli, M. G. Tadros, A. E. Khalifa, H. A. Mosli, and A. B. Abdel-Naim, “Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 12, pp. 1131–1140, 2014. View at Publisher · View at Google Scholar · View at Scopus